| 1 |
35110502 | RSK-Mediated Non-canonical Activation of EphA2 by Tamoxifen. | 2022 |
1 |
| 2 |
33861751 | CSNK1G2 differently sensitizes tamoxifen-induced decrease in PI3K/AKT/mTOR/S6K and ERK signaling according to the estrogen receptor existence in breast cancer cells. | 2021 |
5 |
| 3 |
33950995 | Bacterial extracellular vesicles affect endocrine therapy in MCF7 cells. | 2021 May 7 |
1 |
| 4 |
34182538 | GPR30-mediated HMGB1 upregulation in CAFs induces autophagy and tamoxifen resistance in ERα-positive breast cancer cells. | 2021 Jun 28 |
2 |
| 5 |
34209871 | NR4A1 Regulates Tamoxifen Resistance by Suppressing ERK Signaling in ER-Positive Breast Cancer. | 2021 Jun 29 |
5 |
| 6 |
34370280 | PI3K/AKT and MAPK1 molecular changes preceding matrix metallopeptidases overexpression during tamoxifen-resistance development are correlated to poor prognosis in breast cancer patients. | 2021 Nov |
5 |
| 7 |
32435229 | IGFBP-1 Expression Promotes Tamoxifen Resistance in Breast Cancer Cells via Erk Pathway Activation. | 2020 |
2 |
| 8 |
33177647 | Coffee decoction enhances tamoxifen proapoptotic activity on MCF-7 cells. | 2020 Nov 11 |
1 |
| 9 |
30795784 | Aberrant fatty acid profile and FFAR4 signaling confer endocrine resistance in breast cancer. | 2019 Feb 22 |
1 |
| 10 |
28988130 | KLF4 overcomes tamoxifen resistance by suppressing MAPK signaling pathway and predicts good prognosis in breast cancer. | 2018 Jan |
2 |
| 11 |
28231748 | Aloe-Emodin Enhances Tamoxifen Cytotoxicity by Suppressing Ras/ERK and PI3K/mTOR in Breast Cancer Cells. | 2017 |
2 |
| 12 |
28423577 | The cyclin-like protein, SPY1, regulates the ERα and ERK1/2 pathways promoting tamoxifen resistance. | 2017 Apr 4 |
1 |
| 13 |
28902352 | GPER promotes tamoxifen-resistance in ER+ breast cancer cells by reduced Bim proteins through MAPK/Erk-TRIM2 signaling axis. | 2017 Oct |
1 |
| 14 |
26780941 | MEK activity controls IL-8 expression in tamoxifen-resistant MCF-7 breast cancer cells. | 2016 Apr |
1 |
| 15 |
27507046 | RAD51 inhibition in triple negative breast cancer cells is challenged by compensatory survival signaling and requires rational combination therapy. | 2016 Sep 13 |
1 |
| 16 |
27519631 | Tamoxifen has a proliferative effect in endometrial carcinoma mediated via the GPER/EGFR/ERK/cyclin D1 pathway: A retrospective study and an in vitro study. | 2016 Dec 5 |
1 |
| 17 |
25430564 | PKC/MEK inhibitors suppress oxaliplatin-induced neuropathy and potentiate the antitumor effects. | 2015 Jul 1 |
1 |
| 18 |
24407515 | Inhibition of GSK-3β activity can result in drug and hormonal resistance and alter sensitivity to targeted therapy in MCF-7 breast cancer cells. | 2014 |
1 |
| 19 |
24481325 | GPER-mediated proliferation and estradiol production in breast cancer-associated fibroblasts. | 2014 Apr |
1 |
| 20 |
24658355 | Functional analysis of MKP-1 and MKP-2 in breast cancer tamoxifen sensitivity. | 2014 Feb 28 |
2 |
| 21 |
24684682 | ERK/MAPK regulates ERRγ expression, transcriptional activity and receptor-mediated tamoxifen resistance in ER+ breast cancer. | 2014 May |
1 |
| 22 |
24916398 | Snail and Slug mediate tamoxifen resistance in breast cancer cells through activation of EGFR-ERK independent of epithelial-mesenchymal transition. | 2014 Aug |
1 |
| 23 |
23609470 | Estrogen receptor α is the major driving factor for growth in tamoxifen-resistant breast cancer and supported by HER/ERK signaling. | 2013 May |
4 |
| 24 |
21863258 | Alteration of Y-box binding protein-1 expression modifies the response to endocrine therapy in estrogen receptor-positive breast cancer. | 2012 May |
1 |
| 25 |
22427054 | Role of PKC-ERK signaling in tamoxifen-induced apoptosis and tamoxifen resistance in human breast cancer cells. | 2012 Jun |
10 |
| 26 |
23029174 | Low ERK phosphorylation in cancer-associated fibroblasts is associated with tamoxifen resistance in pre-menopausal breast cancer. | 2012 |
4 |
| 27 |
21044952 | Integrated quantitative analysis of the phosphoproteome and transcriptome in tamoxifen-resistant breast cancer. | 2011 Jan 7 |
1 |
| 28 |
21175263 | Ubiquitin ligase c-Cbl is involved in tamoxifen-induced apoptosis of MCF-7 cells by downregulating the survival signals. | 2011 Jun |
2 |
| 29 |
21573702 | PI3-kinase/p38 kinase-dependent E2F1 activation is critical for Pin1 induction in tamoxifen-resistant breast cancer cells. | 2011 Jul |
1 |
| 30 |
21595894 | Elevated insulin-like growth factor 1 receptor signaling induces antiestrogen resistance through the MAPK/ERK and PI3K/Akt signaling routes. | 2011 May 19 |
2 |
| 31 |
21869603 | Involvement of Akt and mTOR in chemotherapeutic- and hormonal-based drug resistance and response to radiation in breast cancer cells. | 2011 Sep 1 |
1 |
| 32 |
21881167 | Cooperative effects of Akt-1 and Raf-1 on the induction of cellular senescence in doxorubicin or tamoxifen treated breast cancer cells. | 2011 Aug |
1 |
| 33 |
19288272 | Growth of hormone-dependent MCF-7 breast cancer cells is promoted by constitutive caveolin-1 whose expression is lost in an EGF-R-mediated manner during development of tamoxifen resistance. | 2010 Feb |
1 |
| 34 |
20524045 | Zinc(II) ion mediates tamoxifen-induced autophagy and cell death in MCF-7 breast cancer cell line. | 2010 Dec |
2 |
| 35 |
20689759 | Ron receptor tyrosine kinase activation confers resistance to tamoxifen in breast cancer cell lines. | 2010 Aug |
1 |
| 36 |
19002577 | Tamoxifen and ICI 182,780 increase Bcl-2 levels and inhibit growth of breast carcinoma cells by modulating PI3K/AKT, ERK and IGF-1R pathways independent of ERalpha. | 2009 Dec |
1 |
| 37 |
18406603 | The ins and outs of GPR30: a transmembrane estrogen receptor. | 2008 Apr |
1 |
| 38 |
17264668 | Is ERK activation a good biomarker for estradiol and tamoxifen effects? | 2007 Jan |
1 |
| 39 |
17355262 | Critical role of estrogen receptor on anoikis and invasion of squamous cell carcinoma. | 2007 May |
2 |
| 40 |
17685427 | Sp3-mediated VEGF regulation is dependent on phosphorylation by extra-cellular signals regulated kinases (Erk). | 2007 Nov |
1 |
| 41 |
15806151 | ERK phosphorylation is linked to VEGFR2 expression and Ets-2 phosphorylation in breast cancer and is associated with tamoxifen treatment resistance and small tumours with good prognosis. | 2005 Jun 23 |
1 |
| 42 |
14645110 | Tamoxifen inhibits cell proliferation via mitogen-activated protein kinase cascades in human ovarian cancer cell lines in a manner not dependent on the expression of estrogen receptor or the sensitivity to cisplatin. | 2004 Mar |
3 |
| 43 |
9090707 | Activation of signal transduction kinases by tamoxifen. | 1997 Feb |
7 |
| 44 |
9372245 | CGP 41251 and tamoxifen selectively inhibit mitogen-activated protein kinase activation and c-Fos phosphoprotein induction by substance P in human astrocytoma cells. | 1997 Nov |
1 |